FDA NDC
Neuraceq
This name is from the loaded FDA file.
Source: FDA NDC Directory, live from openFDA. Publisher page
- NDC
- 54828-001
- Proprietary name
- Neuraceq
- Nonproprietary name
- Florbetaben F 18
- Labeler
- Lantheus Biosciences Ltd., a Lantheus company
- Dosage form
- INJECTION, SOLUTION
- Strength
- 135 mCi/mL
Run it in Rivvi
Which 2027 plans near you dropped or restricted Florbetaben F 18?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan, from the CMS Part D files.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.